Filing Details
- Accession Number:
- 0001640455-20-000116
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-09-16 18:43:43
- Reporting Period:
- 2020-09-15
- Accepted Time:
- 2020-09-16 18:43:43
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1640455 | Jounce Therapeutics Inc. | JNCE | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1353128 | Gayle Barbara Duncan | C/O Jounce Therapeutics, Inc. 780 Memorial Drive Cambridge MA 02139 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-09-15 | 10,000 | $4.21 | 10,000 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-09-15 | 5,000 | $9.50 | 5,000 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-09-15 | 5,000 | $10.50 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-09-15 | 10,000 | $0.00 | 10,000 | $4.21 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 34,271 | 2026-05-09 | No | 4 | M | Direct |
Footnotes
- The transactions reported on this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on December 20, 2019. The Reporting Person exercised no discretion with respect to these transactions.
- The option shares vested and became exercisable in 16 quarterly installments from May 10, 2016.
Billionaire Hedge Funds
